3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
11
Phase 1/2
5
Phase 3
4
Phase NA
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
HIV Infections
1
Interventions
Cyclophosphamide
4
Vincristine
2
selinexor
1
fludarabine phosphate
1
fludarabine
1
axicabtagene ciloleucel
1
apatinib
1
VAP-cyclo protocol
1
Thiotepa
1
Rituximab
1
Radiotherapy
1
R-CHOP protocol
1
Prednisone
1
Nurse Clinicians
1
Methotrexate
1
Melphalan
1
Lomustine
1
Ifosfamide
1
Idarubicin
1
Filgrastim
1
Etoposide
1
Epirubicin
1
Doxorubicin
1
Dexamethasone
1
Decitabine
1
Cytarabine
1
Carmustine
1
Brentuximab Vedotin
1
Blood Pressure
1
Antiretroviral Therapy, Highly Active
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lymphoma, Large B-Cell, Diffuse
×
R-CHOP protocol
×
Clear all
NCT00466258
2009-11-25
LINFOTARGAM
PETHEMA Foundation
Phase 4
Completed
50 enrolled